Difference in Neutropenia due to Administration Schedule of TAS-102
TAS-102 significantly improves overall survival in patients with metastatic colorectal cancer. The most common adverse event of TAS-102 is bone marrow suppression, which leads to neutropenia. The incidence of neutropenia is high, and there is no known effective prevention method. Furthermore, the ad...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Karger Publishers
2017-03-01
|
| Series: | Case Reports in Oncology |
| Assuntos: | |
| Acceso en liña: | http://www.karger.com/Article/FullText/460242 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|